165 related articles for article (PubMed ID: 9373310)
1. Affinity improvement of single antibody VH domains: residues in all three hypervariable regions affect antigen binding.
Davies J; Riechmann L
Immunotechnology; 1996 Sep; 2(3):169-79. PubMed ID: 9373310
[TBL] [Abstract][Full Text] [Related]
2. Heavy chain CDR3 optimization of a germline encoded recombinant antibody fragment predisposed to bind the U1A protein.
de Wildt RM; Ruytenbeek R; van Venrooij WJ; Hoet RM
Protein Eng; 1997 Jul; 10(7):835-41. PubMed ID: 9342149
[TBL] [Abstract][Full Text] [Related]
3. Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain.
Chen W; Zhu Z; Feng Y; Xiao X; Dimitrov DS
J Mol Biol; 2008 Oct; 382(3):779-89. PubMed ID: 18687338
[TBL] [Abstract][Full Text] [Related]
4. Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains.
Muyldermans S; Atarhouch T; Saldanha J; Barbosa JA; Hamers R
Protein Eng; 1994 Sep; 7(9):1129-35. PubMed ID: 7831284
[TBL] [Abstract][Full Text] [Related]
5. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
6. An antibody single-domain phage display library of a native heavy chain variable region: isolation of functional single-domain VH molecules with a unique interface.
Reiter Y; Schuck P; Boyd LF; Plaksin D
J Mol Biol; 1999 Jul; 290(3):685-98. PubMed ID: 10395823
[TBL] [Abstract][Full Text] [Related]
7. Antibody VH domains as small recognition units.
Davies J; Riechmann L
Biotechnology (N Y); 1995 May; 13(5):475-9. PubMed ID: 9634788
[TBL] [Abstract][Full Text] [Related]
8. Binders based on dimerised immunoglobulin VH domains.
Sepúlveda J; Jin H; Sblattero D; Bradbury A; Burrone OR
J Mol Biol; 2003 Oct; 333(2):355-65. PubMed ID: 14529622
[TBL] [Abstract][Full Text] [Related]
9. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
10. Critical binding site amino acids of anti-Z-DNA single chain Fv molecules. Role of heavy and light chain CDR3 and relationship to autoantibody activity.
Polymenis M; Stollar BD
J Immunol; 1994 Jun; 152(11):5318-29. PubMed ID: 8189049
[TBL] [Abstract][Full Text] [Related]
11. By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro.
Hoogenboom HR; Winter G
J Mol Biol; 1992 Sep; 227(2):381-8. PubMed ID: 1404359
[TBL] [Abstract][Full Text] [Related]
12. Generation of a panel of related human scFv antibodies with high affinities for human CEA.
Osbourn JK; Field A; Wilton J; Derbyshire E; Earnshaw JC; Jones PT; Allen D; McCafferty J
Immunotechnology; 1996 Sep; 2(3):181-96. PubMed ID: 9373311
[TBL] [Abstract][Full Text] [Related]
13. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.
Kabat EA; Wu TT
J Immunol; 1991 Sep; 147(5):1709-19. PubMed ID: 1908882
[TBL] [Abstract][Full Text] [Related]
14. Isolated VH4 heavy chain variable regions bind DNA characterization of a recombinant antibody heavy chain library derived from patient(s) with active SLE.
Kieber-Emmons T; von Feldt JM; Godillot AP; McCallus D; Srikantan V; Weiner DB; Williams WV
Lupus; 1994 Oct; 3(5):379-92. PubMed ID: 7841991
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutation in VH complementarity-determining region 2 and framework region 2: differential effects on antigen binding and Ig secretion.
Wiens GD; Heldwein KA; Stenzel-Poore MP; Rittenberg MB
J Immunol; 1997 Aug; 159(3):1293-302. PubMed ID: 9233625
[TBL] [Abstract][Full Text] [Related]
16. The primary structure and specificity determining residues displayed by recombinant salmon antibody domains.
Solem ST; Brandsdal BO; Smalås A; Jørgensen TØ
Mol Immunol; 2004 Apr; 40(18):1347-60. PubMed ID: 15072853
[TBL] [Abstract][Full Text] [Related]
17. Differences in antigen-binding affinity caused by a single amino acid substitution in the variable region of the heavy chain.
Xiang J; Chen Z; Delbaere LT; Liu E
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():239-47. PubMed ID: 8225393
[TBL] [Abstract][Full Text] [Related]
18. The antibody site in Atlantic salmon; phage display and modeling of scFv with anti-hapten binding ability.
Jørgensen TØ; Solem ST; Espelid S; Warr GW; Brandsdal BO; Smalås A
Dev Comp Immunol; 2002 Mar; 26(2):201-6. PubMed ID: 11696385
[TBL] [Abstract][Full Text] [Related]
19. Single domain antibodies: comparison of camel VH and camelised human VH domains.
Riechmann L; Muyldermans S
J Immunol Methods; 1999 Dec; 231(1-2):25-38. PubMed ID: 10648925
[TBL] [Abstract][Full Text] [Related]
20. Expression of monovalent fragments derived from a human IgM autoantibody in E. coli. The input of the somatically mutated CDR1/CDR2 and of the CDR3 into antigen binding specificity.
Jahn S; Roggenbuck D; Niemann B; Ward ES
Immunobiology; 1995 Aug; 193(5):400-19. PubMed ID: 8522357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
